Capturing Differential Allele-Level Expression and Genotypes of All Classical HLA Loci and Haplotypes by a New Capture RNA-Seq Method.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 03 12 2019
accepted: 22 04 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 7 4 2021
Statut: epublish

Résumé

The highly polymorphic human major histocompatibility complex (MHC) also known as the human leukocyte antigen (HLA) encodes class I and II genes that are the cornerstone of the adaptive immune system. Their unique diversity (>25,000 alleles) might affect the outcome of any transplant, infection, and susceptibility to autoimmune diseases. The recent rapid development of new next-generation sequencing (NGS) methods provides the opportunity to study the influence/correlation of this high level of HLA diversity on allele expression levels in health and disease. Here, we describe the NGS capture RNA-Seq method that we developed for genotyping all 12 classical HLA loci (

Identifiants

pubmed: 32547543
doi: 10.3389/fimmu.2020.00941
pmc: PMC7272581
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

941

Informations de copyright

Copyright © 2020 Yamamoto, Suzuki, Mizutani, Shigenari, Ito, Kametani, Kato, Fernandez-Viña, Murata, Morishima, Morishima, Tanaka, Kulski, Bahram and Shiina.

Références

Genome Med. 2015 Mar 27;7(1):30
pubmed: 25954321
Tissue Antigens. 2014 Jan;83(1):10-6
pubmed: 24355003
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8676-81
pubmed: 22589303
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6787-94
pubmed: 8041698
Scand J Immunol. 2015 Oct;82(4):283-306
pubmed: 26099424
Rheumatology (Oxford). 2012 Oct;51(10):1765-74
pubmed: 22723597
Tissue Antigens. 2014 Jan;83(1):32-40
pubmed: 24355006
J Hum Genet. 2009 Jan;54(1):15-39
pubmed: 19158813
J Immunol Res. 2017;2017:3186328
pubmed: 29333460
Rev Immunogenet. 1999;1(1):105-23
pubmed: 11256568
Tissue Antigens. 2012 Oct;80(4):305-16
pubmed: 22861646
N Engl J Med. 1998 Oct 22;339(17):1177-85
pubmed: 9780337
Immunol Today. 1997 Jan;18(1):14-7
pubmed: 9018968
Cell. 2017 Nov 30;171(6):1259-1271.e11
pubmed: 29107330
Int J Immunogenet. 2009 Feb;36(1):47-57
pubmed: 19207936
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16928-33
pubmed: 12482934
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Tissue Antigens. 2004 Dec;64(6):631-49
pubmed: 15546336
Immunogenetics. 2010 Dec;62(11-12):711-9
pubmed: 20842357
PLoS One. 2016 Oct 20;11(10):e0164292
pubmed: 27764126
Nature. 2003 Oct 23;425(6960):805-11
pubmed: 14574404
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31
pubmed: 25414341
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
Mol Biol Evol. 2003 Sep;20(9):1377-419
pubmed: 12777501
Hum Immunol. 2015 Dec;76(12):887-90
pubmed: 25777625
BMC Genomics. 2015 Apr 18;16:318
pubmed: 25895492
Blood. 2015 Feb 12;125(7):1189-97
pubmed: 25519752
Nat Commun. 2017 Jun 26;8:15924
pubmed: 28649982
Genes Immun. 2014 Apr-May;15(3):176-81
pubmed: 24500399
Cell Prolif. 2011 Apr;44 Suppl 1:60-9
pubmed: 21481046
Blood. 2014 Dec 18;124(26):3996-4003
pubmed: 25323824
Annu Rev Genomics Hum Genet. 2013;14:301-23
pubmed: 23875801
J Int Med Res. 2010 May-Jun;38(3):949-56
pubmed: 20819431
J Virol. 2012 Jun;86(12):6979-85
pubmed: 22496224
Sci Rep. 2018 Aug 9;8(1):11924
pubmed: 30093645
Rheumatology (Oxford). 2002 Dec;41(12):1375-9
pubmed: 12468816
Hum Immunol. 2000 Apr;61(4):389-96
pubmed: 10715516
Nat Genet. 2009 Dec;41(12):1290-4
pubmed: 19935663
PLoS Genet. 2019 Apr 22;15(4):e1008091
pubmed: 31009447
Nat Rev Immunol. 2005 Oct;5(10):793-806
pubmed: 16200082
Nat Protoc. 2014 May;9(5):989-1009
pubmed: 24705597
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951
pubmed: 29093164
Cancer Immunol Res. 2014 Nov;2(11):1071-9
pubmed: 25116754
J Immunol. 1993 Mar 15;150(6):2263-72
pubmed: 8450211
Oncoimmunology. 2014 Aug 03;3(8):e954893
pubmed: 25960936
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
N Engl J Med. 2015 Aug 13;373(7):669-72
pubmed: 26267627
Front Immunol. 2018 Oct 04;9:2294
pubmed: 30337930
Nature. 2013 Sep 26;501(7468):506-11
pubmed: 24037378
Science. 2013 Apr 5;340(6128):87-91
pubmed: 23559252
Hum Mol Genet. 2015 Aug 1;24(15):4268-75
pubmed: 25935001
Physiol Genomics. 2017 Mar 1;49(3):193-200
pubmed: 28130428
N Engl J Med. 2015 Aug 13;373(7):599-609
pubmed: 26267621
J Mol Med (Berl). 2005 Feb;83(2):97-109
pubmed: 15592805
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
Sci Rep. 2018 Mar 19;8(1):4781
pubmed: 29556074
J Hum Genet. 2015 Nov;60(11):665-73
pubmed: 26311539
Front Immunol. 2017 May 19;8:583
pubmed: 28579988
Nature. 2011 Apr 28;472(7344):495-8
pubmed: 21499264
BMC Genomics. 2017 Nov 28;18(1):914
pubmed: 29179676
J Immunol. 2017 Mar 15;198(6):2320-2329
pubmed: 28148735
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20705-10
pubmed: 24248364
J Mol Med (Berl). 2014 Dec;92(12):1293-304
pubmed: 25146850

Auteurs

Fumiko Yamamoto (F)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, United States.
Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Shingo Suzuki (S)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Akiko Mizutani (A)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Faculty of Health and Medical Science, Teikyo Heisei University, Toshima-ku, Tokyo, Japan.

Atsuko Shigenari (A)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Sayaka Ito (S)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Yoshie Kametani (Y)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Shunichi Kato (S)

Division of Hematopoietic Cell Transplantation, Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.

Marcelo Fernandez-Viña (M)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, United States.
Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Stanford Health Care, Palo Alto, CA, United States.

Makoto Murata (M)

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Satoko Morishima (S)

Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.

Yasuo Morishima (Y)

Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan.

Masafumi Tanaka (M)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Jerzy K Kulski (JK)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Faculty of Health and Medical Sciences, The University of Western Australia Medical School, Crawley, WA, Australia.

Seiamak Bahram (S)

Laboratoire d'ImmunoRhumatologie Moléculaire, Plateforme GENOMAX, INSERM UMR_S 1109, LabEx TRANSPLANTEX, Fédération Hospitalo-Universitaire OMICARE, Laboratoire International Associé INSERM FJ-HLA-Japan, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de Médecine, Université de Strasbourg, Service d'Immunologie Biologique, Nouvel Hôpital Civil, Strasbourg, France.

Takashi Shiina (T)

Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH